Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
Nishioka
Yoshiaki
Y
Department of Internal Medicine, Nagasaki Municipal Medical Center, 20-5 Fuchi-machi, Nagasaki 852-8012, Japan. yyynnn@mxc.cncm.ne.jp
Horita
Yoshio
Y
Tadokoro
Masato
M
Taura
Koichi
K
Suyama
Naofumi
N
Miyazaki
Masanobu
M
Harada
Takashi
T
Kohno
Shigeru
S
D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000378:metabolism*; D005260:Female; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction; D012263:Ribonucleosides / Q000627:therapeutic use*; D014657:Vasculitis / Q000188:drug therapy* / Q000276:immunology
D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D007168:IMP Dehydrogenase